Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,158,745
+$119,383 QoQ
Shares Held
8,500
+1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,280
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LYELL WEALTH MANAGEMENT, LP holds $9,885,867 across 8 Drug Manufacturers - General names. JNJ ranks #2 (21.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,847 | $3,414,777 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
8,500 | $2,158,745 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,816 | $1,389,856 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
7,276 | $919,249 | |
| 5 | ABBV |
AbbVie Inc.
|
3,619 | $910,685 | |
| 6 | AMGN |
Amgen Inc
|
1,688 | $611,258 | |
| 7 | AZN |
Astrazeneca PLC
|
1,377 | $261,106 | |
| 8 | NVS |
Novartis AG
|
1,405 | $220,191 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,158,745 | 8,500 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,039,362 | 8,343 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,643,803 | 7,943 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,365,803 | 7,366 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,170,370 | 7,662 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,062,205 | 6,405 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,075,828 | 7,439 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,188,710 | 7,335 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $1,071,645 | 7,332 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,117,612 | 7,065 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,190,597 | 7,596 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $700,407 | 4,497 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $751,957 | 4,543 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $704,165 | 4,543 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $830,431 | 4,701 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $753,252 | 4,611 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $804,652 | 4,533 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $787,432 | 4,443 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $714,046 | 4,174 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $670,871 | 4,154 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $685,153 | 4,159 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $566,514 | 3,447 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $539,813 | 3,430 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $495,174 | 3,326 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $430,327 | 3,060 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $454,365 | 3,465 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||